Application 203683
- Type
- ANDA
- Sponsor
- WATSON LABS INC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | NEBIVOLOL HYDROCHLORIDE | NEBIVOLOL HYDROCHLORIDE | TABLET;ORAL | EQ 2.5MG BASE | No | No |
| 002 | NEBIVOLOL HYDROCHLORIDE | NEBIVOLOL HYDROCHLORIDE | TABLET;ORAL | EQ 5MG BASE | No | No |
| 003 | NEBIVOLOL HYDROCHLORIDE | NEBIVOLOL HYDROCHLORIDE | TABLET;ORAL | EQ 10MG BASE | No | No |
| 004 | NEBIVOLOL HYDROCHLORIDE | NEBIVOLOL HYDROCHLORIDE | TABLET;ORAL | EQ 20MG BASE | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A203683-001 | NEBIVOLOL HYDROCHLORIDE | NEBIVOLOL HYDROCHLORIDE | EQ 2.5MG BASE | TABLET / ORAL | 2015-11-27 | ||
| A203683-002 | NEBIVOLOL HYDROCHLORIDE | NEBIVOLOL HYDROCHLORIDE | EQ 5MG BASE | TABLET / ORAL | 2015-11-27 | ||
| A203683-003 | NEBIVOLOL HYDROCHLORIDE | NEBIVOLOL HYDROCHLORIDE | EQ 10MG BASE | TABLET / ORAL | 2015-11-27 | ||
| A203683-004 | NEBIVOLOL HYDROCHLORIDE | NEBIVOLOL HYDROCHLORIDE | EQ 20MG BASE | TABLET / ORAL | 2015-11-27 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A203683-001 | NEBIVOLOL HYDROCHLORIDE | EQ 2.5MG BASE | TABLET / ORAL | 2015-11-27 | a50c72e98297… | ||
| 2026-08-01 22:54:32 | 2026-06 | A203683-002 | NEBIVOLOL HYDROCHLORIDE | EQ 5MG BASE | TABLET / ORAL | 2015-11-27 | a50c72e98297… | ||
| 2026-08-01 22:54:32 | 2026-06 | A203683-003 | NEBIVOLOL HYDROCHLORIDE | EQ 10MG BASE | TABLET / ORAL | 2015-11-27 | a50c72e98297… | ||
| 2026-08-01 22:54:32 | 2026-06 | A203683-004 | NEBIVOLOL HYDROCHLORIDE | EQ 20MG BASE | TABLET / ORAL | 2015-11-27 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| nebivolol | NEBIVOLOL HYDROCHLORIDE | AvKARE | 1ce89dc5-018d-db40-e063-6294a90a9722 | 2026-01-16 | Warnings, Adverse reactions | NEBIVOLOL HYDROCHLORIDE |
| nebivolol | NEBIVOLOL HYDROCHLORIDE | Apnar Pharma LP | 3f5766c0-e1fa-4805-a32c-523182310ad5 | 2025-02-14 | Warnings, Adverse reactions | NEBIVOLOL HYDROCHLORIDE |
| Bystolic | NEBIVOLOL HYDROCHLORIDE | Allergan, Inc. | 8b8ad213-1dc8-454e-a524-075685c0e1a8 | 2024-08-01 | Warnings, Adverse reactions | NEBIVOLOL HYDROCHLORIDE |
| nebivolol | NEBIVOLOL HYDROCHLORIDE | Glenmark Pharmaceuticals Inc., USA | cb47560d-9e35-4b0f-b12b-6ea478684a5b | 2023-08-01 | Warnings, Adverse reactions | NEBIVOLOL HYDROCHLORIDE |
| Nebivolol Hydrochloride | NEBIVOLOL HYDROCHLORIDE | Unichem Pharmaceuticals (USA), Inc. | b1762bbb-b5be-48a7-8101-bb736f28845a | 2023-07-11 | Warnings, Adverse reactions | Nebivolol Hydrochloride NEBIVOLOL HYDROCHLORIDE |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 10244 | ORIG | 2015-12-01 |